Clover Health (CLOV) Response to Short Seller 'Compelling' - BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
Clover Health Investments (CLOV) Issues Response to Short Seller Hindenburg Research
February 5, 2021 6:20 AM ESTClover Health Investments (NASDAQ: CLOV) issued a response to an article by Hindenburg Research
From:
Vivek Garipalli, CEO and Andrew Toy, President of Clover Health
Clovers mission is to improve every life. We do that by scaling the Clover Assistant platform across physicians to drive a meaningful positive clinical impact towards as wide a percentage of our membership as possible. We align our incentives for the Clover Assistant by embedding our software platform inside of the business of our Medicare Advantage plan. As we improve outcomes, and lower costs, Clover can pass... More
Clover Health Investments (CLOV) Confirms SEC Investigation
February 5, 2021 6:20 AM ESTClover Health Investments (NASDAQ: CLOV) said ollowing the publication of an article by Hindenburg Research on February 4, 2021, concerning the recently completed business combination of Clover Health Investments, Corp., the Company received a letter from the Securities and Exchange Commission (the SEC) indicating that it is... More
